Significant antifracture efficacy of oral ibandronate in women with low bone mass

被引：0
|
作者：
Lorenc, R
Felsenberg, D
Stakkestad, JA
Gibride, J
Schimmer, RC
机构：
[1] Childrens Mem Inst, Warsaw, Poland
[2] Univ Klinikum Benjamin Franklin, Osteoporose Forsch Grp, Berlin, Germany
[3] CECOR AS, Haugesund, Norway
[4] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 452
页数：1
相关论文
共 50 条
  • [21] Has exercise an antifracture efficacy in women?
    Karlsson, M
    [J]. SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2004, 14 (01) : 2 - 15
  • [22] The rigorous fracture diagnosis methodology used in the pivotal phase III study supports the antifracture efficacy of oral daily and intermittent ibandronate
    Felsenberg, D
    Armbrecht, G
    Blenk, T
    Chesnut, CH
    Gardner, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S106 - S106
  • [23] Ibandronate: Extending treatment options with oral monthly and quarterly IV injection dosing, from bone quality to antifracture protection - Foreword
    Papapoulos, Socrates E.
    [J]. BONE, 2007, 41 (05) : S2 - S2
  • [24] ONCE-MONTHLY ORAL IBANDRONATE TREATMENT IN AN ADOLESCENT WITH RECURRENT FRACTURES AND INADEQUATELY LOW BONE MASS
    Kutilek, Stepan
    Plasilova, Ivana
    Nemec, Vladimir
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2012, 48 (07) : 622 - 623
  • [25] Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss
    McClung, Michael R.
    Bolognese, Michael A.
    Sedarati, Farhad
    Recker, Robert R.
    Miller, Paul D.
    [J]. BONE, 2009, 44 (03) : 418 - 422
  • [26] Efficacy and safety of monthly ibandronate in men with low bone density
    Orwoll, Eric S.
    Binkley, Neil C.
    Lewiecki, E. Michael
    Gruntmanis, Ugis
    Fries, Michael A.
    Dasic, Gorana
    [J]. BONE, 2010, 46 (04) : 970 - 976
  • [27] Ibandronate: Extending treatment options with oral monthly and quarterly IV injection dosing, from bone quality to antifracture protection - Introduction
    Bouillon, Roger
    [J]. BONE, 2007, 41 (05) : S1 - S1
  • [28] Correlates of use of antifracture therapy in older women with low bone mineral density
    Ryder, KM
    Shorr, RI
    Tylavsky, FA
    Bush, AJ
    Bauer, DC
    Simonsick, EM
    Strotmeyer, ES
    Harris, TB
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (06) : 636 - 641
  • [29] Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis
    Recker, R
    Stakkestad, JA
    Chesnut, CH
    Christiansen, C
    Skag, A
    Hoiseth, A
    Ettinger, M
    Mahoney, P
    Schimmer, RC
    Delmas, DP
    [J]. BONE, 2004, 34 (05) : 890 - 899
  • [30] Correlates of use of antifracture therapy in older women with low bone mineral density
    Kathryn M. Ryder
    Ronald I. Shorr
    Frances A. Tylavsky
    Andrew J. Bush
    Douglas C. Bauer
    Eleanor M. Simonsick
    Elsa S. Strotmeyer
    Tamara B. Harris
    [J]. Journal of General Internal Medicine, 2006, 21 : 636 - 641
12345